QualityStocks Stock Newsletters Archives - Page 1064 of 1818

WednesdayApr 30, 2008 5:09 pm

Conspiracy Entertainment Corp. (CPYE.OB) Teams with Blast! Entertainment to Launch “Garfield: Lasagna World Tour” in the Second Quarter

Conspiracy Entertainment Corporation (CPYE.OB), a developer, publisher and marketer of interactive entertainment software in North America and Western Europe, announced a development agreement with Blast! Entertainment, the leading video game company aimed exclusively at the younger children’s market, to launch a 3-D adventure video game based on the popular cartoon cat Garfield. In this video game, Garfield and his hungry stomach are up to the challenge of a worldwide treasure hunt for the chance to win his weight in lasagna for life! In this game, players can guide Garfield through 10 vast levels of international lasagna eating in Mexico, Italy…

WednesdayApr 30, 2008 5:07 pm

YTB International, Inc. (YTBLA.OB) Appoints Robert H. Dickinson and Burt L. Saunders, Esq. to Board of Directors

YTB International, Inc. (YTBLA.OB), a provider of Internet-based travel booking services for travel agencies and home-based independent representatives in the United States, Bermuda, the Bahamas and Canada, announced the appointment of Robert H. Dickinson and Burt L. Saunders, Esq. to the company’s board of directors, effective immediately. Mr. Dickinson previously served as president and chief executive officer of the Carnival Cruise Lines division of Carnival Corporation and as the company’s chief operating officer for more than more than 10 years. Mr. Dickinson earned his MBA from Duquesne University and received his B.S.B.A in management from John Carroll University. Mr. Saunders…

WednesdayApr 30, 2008 5:05 pm

Key Tronic Corp. (KTCC) Reports Third Quarter Earnings

Third quarter figures were reported recently by Key Tronic Corporation (NASD: KTCC), a provider of electronic manufacturing services (EMS). The quarter ended on March 29, 2008. In the after-hours of Tuesday's trading, the company's stock rose 33.85%. The company reported total revenue of $51.5 million, up 9% from $47.2 million in the same period of last year's figures. During the first nine months of fiscal 2008, total revenue was $146.8 million, lower than last year's number of $152.6 million during the same period. Net income for the third quarter of fiscal 2008 was $1.2 million or $0.11 per diluted share,…

WednesdayApr 30, 2008 10:29 am

Actiga Corp. (AGAC.OB) Subsidiary to Launch Microsoft Endorsed Line of Game Controllers

Actiga Corporation (OTCBB: AGAC) today announced its wholly-owned subsidiary, Qmotions, has signed a North American licensing agreement with Microsoft Corp. (Nasdaq: MSFT). The agreement will allow Qmotions to incorporate Microsoft’s Xbox 360 wireless technology in its own game controllers and will produce a full line of products officially endorsed by Microsoft. “This is a milestone event for our company that now enables us to design, develop and market a unique range of wireless products, bringing the excitement of action gaming to a whole new level on the Xbox 360 system,” Amro Albanna, chairman and CEO of Actiga stated in the…

WednesdayApr 30, 2008 10:01 am

Doral Energy Corp. (DENG.OB) Changes Name and Agrees to Purchase New Property

Effective April 28, 2008, Language Enterprises Corp has changed its name to Doral Energy Corp. Shareholders’ approval was not required to change the company’s name. No changes were made to the company's articles of incorporation or bylaws and the company will continue its existing business as an emerging oil and gas exploration and production company. In addition to the name change, the company has agreed to acquire a significant package of oil and gas producing properties in southeastern New Mexico in the northwest section of the Permian Basin. The property is currently producing approximately 120 gross barrels of oil equivalent…

WednesdayApr 30, 2008 9:58 am

Angiotech Pharmaceuticals, Inc. (ANPI) Adjusts for Remainder of 2008

Angiotech Pharmaceuticals (ANPI), a global specialty pharmaceutical and medical device company, announced its financial results for the first quarter 2008. Angiotech reported a $3.9 million loss for the first quarter, which equals a 5 cent loss per share. Analysts had projected a loss of 3 cents per share. Angiotech made a number changes in their internal control systems to strengthen their financial reporting process and reduce the incidence of errors. The weakness in the process was described in the March 13, 2008 release that announced the company’s 2007 year-end financial results. Angiotech has engaged a large public accounting firm to…

WednesdayApr 30, 2008 9:56 am

PTS Inc. (PTSH.OB) Forms New Subsidiary to Strengthen U.S. and Chinese Ties

PTS Inc. (OTCBB: PTSH) today announced it has formed PTS Group Ltd. as a new subsidiary company in Hong Kong, China. PTS Inc. will designate Glove Box Inc. into the subsidiary, as a subsidiary. Management is finalizing negotiations for a Letter of Intent for a Joint Venture or acquisition of the medical equipment company. The proposed endeavor will allow PTS Inc. to further develop and market Glove Box alongside its existing medical equipment product lines. PTS Group will follow Hong Kong Companies Ordinance regulations, and will be compliant with the rules and regulations of the U.S. Securities and Exchange commission…

WednesdayApr 30, 2008 9:52 am

CEVA, Inc. (CEVA) Grows by Leaps and Bounds in '08

CEVA bills itself as a leading licensor of Silicon Intellectual Property (SIP) platform solutions and Digital Signal Processor (DSP) cores for consumer mobile-electronics. Yesterday, CEVA, Inc. reported first quarter financial results which stand to push it further toward success in the Intellectual Property sector. From the beginning of January until the end of March, the company recorded over $10 million in total revenue; 30 percent higher than the $7.7 million attained in the first quarter of 2007. CEVA's royalty revenue (commonly associated with IP licensing) reached an all-time high of $3.7 million, and earnings from services also showed a significant…

WednesdayApr 30, 2008 7:21 am

Genetech Inc. (DNA); Biogen Idec Inc. (BIIB) – Promising Drug Falls Short

The drug Rituxan, which is marketed by both Genetech Inc. (DNA) and partner Biogen Idec Inc. (BIIB), has failed to make any headway in the fight against lupus, a disease affecting the immune system and targeting more than one million Americans each year. There has never been much progress toward a cure, and some felt that Rituxan would be that miracle. The medication is already approved as a treatment for rheumatoid arthritis and some types of cancer, but the hope - that Rituxan might be effective against lupus - has fallen through. While the companies realize the serious challenges in…

WednesdayApr 30, 2008 7:07 am

3Com Corp. (COMS) Has a New CEO

3Com Corporation (NASDAQ: COMS) announced yesterday that the company's board of directors has appointed Robert Mao as the new Chief Executive Officer. He is replacing Edgar Masri, who is leaving the company. Mao will continue to serve on the company's board. 3Com also hired Ronald Sege as President and Chief Operating Officer and appointed him to the board effective today. “We wish to thank Edgar for his leadership and contributions to 3Com," said Chairman of 3Com's Board of Directors, Eric Benhamou. "Edgar helped the company through a challenging period and helped us make progress on a number of fronts, including…

Site Search

Company Search

Category: QualityStocks Stock Newsletters